ZBNA
AMRX icon

Zions Bancorporation, National Association’s Amneal Pharmaceuticals AMRX Stock Holding History

Zions Bancorporation, National Association’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55K Buy
263
+58
+28% +$795 ﹤0.01% 1094
2026
Q1 		$2.55K Buy
205
+158
+336% +$2.12K ﹤0.01% 1149
2025
Q4 		$592 Buy
+47
New +$538 ﹤0.01% 1186

Other funds holding AMRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CIP
Convergence Investment Partners Palm Beach Gardens, Florida $1.06B AUM 87.75% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Zions Bancorporation, National Association's AMRX Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Amneal Pharmaceuticals (AMRX) stake by 28% in Q2 2026, buying an estimated $795 and bringing the position to 263 shares worth $4.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1094.

Zions Bancorporation, National Association first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 76 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Zions Bancorporation, National Association held 263 shares of Amneal Pharmaceuticals worth $4.55K as of Q2 2026.
  • Zions Bancorporation, National Association bought 58 Amneal Pharmaceuticals shares in Q2 2026, an estimated $795.
  • Amneal Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1094 holding.
  • Zions Bancorporation, National Association first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 76 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.